Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Related Citations for PubMed (Select 23760235)

1.

Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.

Tsai SC, Lin SJ, Lin CJ, Chou YC, Lin JH, Yeh TH, Chen MR, Huang LM, Lu MY, Huang YC, Chen HY, Tsai CH.

J Virol. 2013 Aug;87(16):9041-52. doi: 10.1128/JVI.00541-13. Epub 2013 Jun 12.

2.

The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus.

Kutz H, Reisbach G, Schultheiss U, Kieser A.

Virology. 2008 Feb 20;371(2):246-56. Epub 2007 Oct 29.

3.

Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation.

Chou YC, Lin SJ, Lu J, Yeh TH, Chen CL, Weng PL, Lin JH, Yao M, Tsai CH.

Blood. 2011 Aug 4;118(5):1340-9. doi: 10.1182/blood-2011-02-335448. Epub 2011 Jun 9.

4.
5.

Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus.

Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, Yoshie O.

J Virol. 2004 Feb;78(4):1665-74.

6.
7.

Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines.

Lai HC, Hsiao JR, Chen CW, Wu SY, Lee CH, Su IJ, Takada K, Chang Y.

Virology. 2010 Sep 30;405(2):464-73. doi: 10.1016/j.virol.2010.06.037. Epub 2010 Jul 15.

8.
9.

hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.

Giunco S, Dolcetti R, Keppel S, Celeghin A, Indraccolo S, Dal Col J, Mastorci K, De Rossi A.

Clin Cancer Res. 2013 Apr 15;19(8):2036-47. doi: 10.1158/1078-0432.CCR-12-2537. Epub 2013 Feb 26.

10.

EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.

Le Clorennec C, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bornkamm GW, Feuillard J.

Blood. 2006 Mar 1;107(5):2070-8. Epub 2005 Nov 29.

11.

An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.

Kaye KM, Izumi KM, Li H, Johannsen E, Davidson D, Longnecker R, Kieff E.

J Virol. 1999 Dec;73(12):10525-30.

12.

EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.

Guasparri I, Bubman D, Cesarman E.

Blood. 2008 Apr 1;111(7):3813-20. doi: 10.1182/blood-2007-03-080309. Epub 2008 Jan 29. Erratum in: Blood. 2008 Jul 15;112(2):452.

13.

The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.

Shkoda A, Town JA, Griese J, Romio M, Sarioglu H, Knöfel T, Giehler F, Kieser A.

PLoS Biol. 2012;10(8):e1001376. doi: 10.1371/journal.pbio.1001376. Epub 2012 Aug 14.

14.

Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.

Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.

J Natl Cancer Inst. 2004 Oct 6;96(19):1447-57.

15.

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.

Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.

Oncogene. 2004 Apr 8;23(15):2681-93. Erratum in: Oncogene. 2004 Oct 21;23(49):8184.

PMID:
14767477
16.

Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.

Le Clorennec C, Ouk TS, Youlyouz-Marfak I, Panteix S, Martin CC, Rastelli J, Adriaenssens E, Zimber-Strobl U, Coll J, Feuillard J, Jayat-Vignoles C.

J Virol. 2008 Jul;82(13):6721-33. doi: 10.1128/JVI.02250-07. Epub 2008 Apr 30.

17.

Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.

Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E.

J Immunol Methods. 2012 Nov 30;385(1-2):60-70. doi: 10.1016/j.jim.2012.08.008. Epub 2012 Aug 18.

PMID:
22921685
18.

The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.

Forte E, Salinas RE, Chang C, Zhou T, Linnstaedt SD, Gottwein E, Jacobs C, Jima D, Li QJ, Dave SS, Luftig MA.

J Virol. 2012 Jun;86(12):6889-98. doi: 10.1128/JVI.07056-11. Epub 2012 Apr 11.

19.

Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder.

Takegawa S, Jin Z, Nakayama T, Oyama T, Hieshima K, Nagakubo D, Shirakawa AK, Tsuzuki T, Nakamura S, Yoshie O.

Cancer Sci. 2008 Feb;99(2):296-302. doi: 10.1111/j.1349-7006.2007.00687.x.

PMID:
18271928
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk